CClinicalTrials.gg
RecruitingNCT06661538I-FRESHUpdated Nov 19, 2025

Implementing Food Referrals for Equity and Sustained Health

A Phase 2 interventional study of Food Security Screening & Referral Program in Food Insecurity, sponsored by University of California, San Diego. Recruiting at 2 sites in United States. Open to participants aged 5 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-19.

Sponsored by University of California, San Diego · Phase 2, Interventional, and Other

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 1 month later.
Phase
Phase 2
Study type
Interventional
Enrollment
600
Allocation
Non-randomized
Ages
5 Years and older
Sex
All
01

Study summary

Food insecurity (FI) disproportionately affects those who have been historically marginalized and significantly contributes to poor health outcomes. In children, FI is associated with lower psychosocial functioning and academic achievement. It also contributes to the development of adverse health outcomes such as obesity, type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Improving the diet quality of children (e.g., decreasing fat intake, increasing fruits and vegetables (FV) and fiber intake) has been associated with lower fasting serum glucose, insulin, LDL cholesterol, non-HDL cholesterol, and reduced risk of CVD later in life. Increasing awareness and access to programs that promote food equity by providing affordable healthy produce is a promising way to improve health outcomes and empower patients and communities to achieve better health and well-being. The goal of this proposal is to refine and optimize implementation strategies that connect families to community-based food security nutrition support programs through health care systems or medical clinics. The investigators will develop a multi-disciplinary, cross-sector collaboration to optimize current processes and workflows that integrate food security nutrition support programs into the healthcare system. The investigators will also work to develop a closed-loop communication system between the healthcare and healthy food access systems to support greater patient autonomy and self-efficacy to obtain, prepare, and consume healthy foods.

Read the detailed description

The investigators will conduct a pilot type 2 hybrid effectiveness-implementation trial of the I-FRESH (Implementing Food Referrals for Equity and Sustained Health) program using a Roll-Out Implementation Optimization (ROIO) design among families with children with nutrition-related illnesses who receive Medicaid or Supplemental Nutrition Assistance Program (SNAP) benefits. The I-FRESH program, the food security nutrition support program, will be refined prior to the first clinic roll-out based on input from several hospital, clinical, and community stakeholders. The program will involve 4 main components: screening and identification of families experiencing food insecurity (FI); social worker/care navigator-led discussions with families to determine need and readiness to receive support; referrals and assistance to engage with these programs; and follow-up assessments to determine fit, track utilization, and determine need for additional referrals. With each roll-out into a new clinic, modified implementation procedures and work-flows will be evaluated using implementation and effectiveness outcomes.

02

Conditions studied

  • Food Insecurity

Keywords

  • Food Insecurity
  • Social Care
  • Screening
  • Type 2 Diabetes Mellitus
  • Cardiovascular Disease
  • Child Health
  • Nutrition
  • Fruit and Vegetables
  • Care Navigation
  • Metabolic Dysfunction-Associated Steatotic Liver Disease
  • NAFLD
  • Nutrition Support Programs
03

In context

Diabetes Mellitus, Type 2

9,359 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.

This study's planned enrollment of 600 is above the median of 80 across 7,525 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.

Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • child attending Type 1 or Type 2 Diabetes clinics, Cardiology clinic, MASLD clinic, general GI clinic at RCHSD
  • child age between 5-18 years old
  • parent or caregiver who indicates that they are experiencing food insecurity and receives Medicaid or SNAP benefits
  • family not moving out of the San Diego area within the time frame of the study

Limited exclusion criteria will be applied in order to examine the impact of this program on a heterogenous group of people and increase generalizability. Of note, all genders and races/ethnicities will be allowed to participate.

05

Study design

Phase
Phase 2
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
600 participants (estimated)

Study arms

  • Experimental
    Clinic 1: Type 2 Diabetes Clinic

    Families with children who attend the Type 2 Diabetes Clinic and indicate that they are experiencing food insecurity on the 2-item screener will be eligible for participation in this group.

    Behavioral: Food Security Screening & Referral Program

  • Experimental
    Clinic 2: Obesity Clinic

    Families with children who attend the Obesity Clinic in Endocrinology and indicate that they are experiencing food insecurity on the 2-item screener will be eligible for participation in this group.

    Behavioral: Food Security Screening & Referral Program

  • Experimental
    Clinic 3: Preventive Cardiology Clinic

    Families with children who attend the Preventive Cardiology Clinic for hypertension and/or high cholesterol and indicate that they are experiencing food insecurity on the 2-item screener will be eligible for participation in this group.

    Behavioral: Food Security Screening & Referral Program

  • Experimental
    Clinic 4: Gastroenterology Clinic

    Families with children who attend the Gastroenterology Clinic for malnutrition or MASLD and indicate that they are experiencing food insecurity on the 2-item screener will be eligible for participation in this group.

    Behavioral: Food Security Screening & Referral Program

Interventions

  • BehavioralFood Security Screening & Referral Program

    The I-FRESH (Implementing Food Referrals for Equity and Sustained Health) program is the food security nutrition support program that involves some combination and form of: 1) screening and identification of families experiencing food insecurity; 2) discussions with families to determine readiness to engage with nutrition support programs and other community resources; 3) referrals and support to engage with a program; and 4) conducting follow-up assessments to determine fit of program, track utilization, and assess need for additional referrals. The exact implementation and workflow for this program will be optimized for each clinic.

06

What researchers measure

Primary outcomes

  1. Feasibility of Intervention Measure (FIM)

    4-item measure that assesses feasibility of implementing the program in that setting; score range (4-20) with higher scores referring to greater feasibility

    Time frame: 12 months

  2. Acceptability of Intervention Measure (AIM)

    4-item measure assessing the acceptability of the program by program staff and participants; score range (4-20) with higher scores referring to greater acceptability

    Time frame: 12 months

  3. Implementation Fidelity

    Percent of families with food insecurity that were called, percent of families that were referred to a program or provided with resources, percent of families that received follow-up phone calls, percent of families that needed additional resources/referrals

    Time frame: 12 months

  4. Adoption

    Percent of clinical settings approached that participate; characteristics of settings participating compared to non participating clinical settings

    Time frame: 12 months

  5. Reach

    Percent of families attending clinic that completed the food insecurity screener, number of families experiencing food insecurity in that clinic, percent of families that wanted and did not want referrals to a nutrition support program

    Time frame: 12 months

Secondary outcomes

  1. Change in Food Security levels over a 12 month period

    U.S. Household Food Security Survey Module: Six-Item Short Form; Score range of 0-6, with higher scores indicating greater food insecurity

    Time frame: 12 months

  2. Change in Weight Status over 12 months

    Weight status may be measured by BMI percentile for age and sex, %BMIp95, %BMIp50, or BMI z-score

    Time frame: 12 months

  3. Change in Blood Pressure over 12 months

    Change in systolic and diastolic blood pressures

    Time frame: 12 months

  4. Change in non-fasting and fasting Lipid levels over 12 months

    Change in total cholesterol, non-HDL cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol

    Time frame: 12 months

  5. Change in HbA1c over 12 months

    change in HbA1c levels over a 12 month period

    Time frame: 12 months

  6. Change in Liver Function Tests over 12 months

    change in AST and ALT over a 12 month period

    Time frame: 12 months

  7. Change in Quality of Life measure over 12 months

    Parent reported Quality of Life as measured by the Pediatric Quality of Life Inventory (PedsQL); Score range of 0 to 100, with higher scores indicating a higher quality of life

    Time frame: 12 months

07

Study locations

1 of 2 sites recruiting
  • UC San Diego
    La Jolla, California 92093, United States
    Active, not recruiting
  • Rady Children's Hospital San Diego
    San Diego, California 92123, United States
    • Kyung Rhee, MD, MS, MA · Contact · k1rhee@health.ucsd.edu · 8589665841
    • Kyung Rhee, MD, MS, MA · Principal investigator
    Recruiting
08

References and documents

Publications

  • Becan JE, Bartkowski JP, Knight DK, Wiley TRA, DiClemente R, Ducharme L, Welsh WN, Bowser D, McCollister K, Hiller M, Spaulding AC, Flynn PM, Swartzendruber A, Dickson MF, Fisher JH, Aarons GA. A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi-site study. Health Justice. 2018 Apr 13;6(1):9. doi: 10.1186/s40352-018-0068-3. PubMed 29654518 ↗
  • Holtrop JS, Estabrooks PA, Gaglio B, Harden SM, Kessler RS, King DK, Kwan BM, Ory MG, Rabin BA, Shelton RC, Glasgow RE. Understanding and applying the RE-AIM framework: Clarifications and resources. J Clin Transl Sci. 2021 May 14;5(1):e126. doi: 10.1017/cts.2021.789. eCollection 2021. PubMed 34367671 ↗
  • McCreight MS, Rabin BA, Glasgow RE, Ayele RA, Leonard CA, Gilmartin HM, Frank JW, Hess PL, Burke RE, Battaglia CT. Using the Practical, Robust Implementation and Sustainability Model (PRISM) to qualitatively assess multilevel contextual factors to help plan, implement, evaluate, and disseminate health services programs. Transl Behav Med. 2019 Nov 25;9(6):1002-1011. doi: 10.1093/tbm/ibz085. PubMed 31170296 ↗
  • Feldstein AC, Glasgow RE. A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice. Jt Comm J Qual Patient Saf. 2008 Apr;34(4):228-43. doi: 10.1016/s1553-7250(08)34030-6. PubMed 18468362 ↗
  • Rhee KE, Hiller-Venegas S, Viglione C, Polich MA, Huang JS, Kim JJ, Bajwa MS, Zive M, Eichen DM, Strong DR, Stadnick NA, Brookman-Frazee L. Roll-Out Implementation Optimization (ROIO) trial to develop and test the implementation of a food security screening and referral process: a study protocol. Implement Sci Commun. 2026 Jun 19. doi: 10.1186/s43058-026-01025-7. Online ahead of print. PubMed 42321957 ↗

Individual participant data

Plan to share: Yes — We will make a complete description of our final study protocol available at the end of the study. We will provide details regarding our study population (inclusion and exclusion criteria as well as demographic information) and describe our strategy for engaging patients, clinicians, and other stakeholders in the design and implementation of this program. We will make available our workflows and specific measurement tools. The program protocol and implementation guide will be made available as well. The study coordinator will be responsible for creating these documents and maintaining them throughout the course of the study, with oversight from Dr. Rhee. External investigators interested in these materials can contact Dr. Rhee via email.

Supporting information: Study protocol, Sap

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06661538
Lead sponsor
University of California, San Diego
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Rady Children's Hospital, San Diego
Responsible party
Kay Rhee (Professor, University of California, San Diego) — Principal investigator
First posted
Oct 28, 2024
Start date
Aug 18, 2025
Primary completion
Jun 15, 2027 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Nov 19, 2025

Study contacts

Kay Rhee, MD, MS, MA
Contact
k1rhee@health.ucsd.edu
858-534-6827

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion